Olistico Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$74.9K Hold
1,200
– – 0.03% 142
2026
Q2
$69.1K Hold
1,200
– – 0.03% 142
2026
Q1
$72.8K Hold
1,200
– – 0.04% 140
2025
Q4
$64.7K Buy
+1,200
New +$57.7K 0.03% 141
2025
Q3
– Sell
-1,200
Closed -$55.5K – 122
2025
Q2
$55.5K Hold
1,200
– – 0.03% 157
2025
Q1
$73.2K Hold
1,200
– – 0.05% 139
2024
Q4
$67.9K Hold
1,200
– – 0.04% 146
2024
Q3
$62.1K Hold
1,200
– – 0.04% 151
2024
Q2
$49.8K Buy
+1,200
New +$53.7K 0.03% 163

Other funds holding BMY

Olistico Wealth's BMY Position: Q3 2026 in Review

Olistico Wealth held its Bristol-Myers Squibb (BMY) position steady in Q3 2026 at 1,200 shares worth $74.9K. The position accounts for 0.03% of the portfolio, ranked #142.

Olistico Wealth first reported a position in BMY in Q2 2024 and has held it in 9 quarters since. 129 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Olistico Wealth held 1,200 shares of Bristol-Myers Squibb worth $74.9K as of Q3 2026.
  • Olistico Wealth left its Bristol-Myers Squibb share count unchanged in Q3 2026.
  • Bristol-Myers Squibb made up 0.03% of Olistico Wealth's portfolio in Q3 2026, its #142 holding.
  • Olistico Wealth first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 9 quarters since.
  • 129 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Olistico Wealth's 13F filing for Q3 2026, filed 5 Oct 2026.